Ingelheim, Germany:Based on results from the EFFISAYIL™ 2 trial, which met its primary and key secondary endpoints for the prevention of generalized...
Bengaluru: Defense Research and Development Organization (DRDO) on Thursday said that its laboratory at Kanpur (Kanpur), Defense Materials and Stores Research and Development Establishment...